David Colquhoun
David Colquhoun (born 19 July 1936) is a British pharmacologist at University College London (UCL). He has contributed significantly to the understanding of ligand-gated ion channels and the application of methods for the analysis of drug-receptor interactions. Colquhoun is also known for his work in promoting the use of evidence-based medicine and criticising pseudoscience and alternative medicine.
Early life and education[edit | edit source]
David Colquhoun was born in Edinburgh, Scotland. He attended the University of Edinburgh, where he received his BSc in Pharmacology in 1959. He then went on to earn his PhD in 1964 from the same institution.
Career[edit | edit source]
After completing his PhD, Colquhoun moved to the University of Southampton, where he worked as a lecturer in pharmacology. In 1969, he joined the faculty of the University of London, where he served as the A.J. Clark Chair of Pharmacology until 2004. He is currently an Honorary Fellow in the Department of Pharmacology at UCL.
Colquhoun's research has focused on the mechanisms of ion channels, particularly those that are activated by neurotransmitters. He has developed mathematical methods for analysing the interactions between drugs and receptors, which have been widely adopted in the field of pharmacology.
In addition to his scientific research, Colquhoun has been a vocal critic of pseudoscience and alternative medicine. He has written extensively on these topics, both in academic journals and on his personal blog, DC's Improbable Science.
Awards and honours[edit | edit source]
Colquhoun has received numerous awards and honours for his contributions to pharmacology and for his advocacy of evidence-based medicine. These include the Wellcome Gold Medal in Pharmacology (1982), the Gaddum Memorial Award (1985), and the Nature Lifetime Achievement Award for Mentoring in Science (2005).
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD